CHECKPOINT THERAPEUTICS, INC.
Profile
Company Names
CHECKPOINT THERAPEUTICS, INC.
Addresses
95 SAWYER ROAD, SUITE 110, WALTHAM, MA 02453
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY 10014
Phone Numbers
781-652-4500
212-554-4366
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2014
State Incorporated:
DELAWARE
Total Amount Raised:
$57,817,000.00
Number of Funding Rounds:
5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2024-07-02
$0.00
INDEFINITE
INDEFINITE
Equity
4
2024-01-27
$0.00
INDEFINITE
INDEFINITE
Equity
3
2023-03-30
$0.00
INDEFINITE
INDEFINITE
2
2023-02-22
$0.00
INDEFINITE
INDEFINITE
1
2015-09-30
$57,817,000.00
$62,500,000.00
$4,683,000.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
NEIL
HERSKOWITZ
DIRECTOR
DAVID
J.
HORIN
EXECUTIVE OFFICER
LINDSAY
A.
ROSENWALD
DIRECTOR
AMIT
SHARMA
DIRECTOR
MICHAEL
WEISS
DIRECTOR
THERMALIN DIABETES, LLC
| SYNTARIS POWER CORP.
| GWP HOLDINGS, INC.
| MANHATTAN PHARMACEUTICALS INC
| RMG GOLF COURSE MANAGEMENT LLC
| ENUMERAL BIOMEDICAL CORP.
| AVENUE THERAPEUTICS, INC.
| FORTRESS BIOTECH, INC.
| CASTLE PEAK FUND I LLC
| AI4, LLC
| RISEANDSHINE CORP
| PARIAN GLOBAL SPECIAL OPPORTUNITY FUND I LP
| GREENBRIAR CO-INVESTMENT LS II, L.P.
| GREENBRIAR CO-INVESTMENT SA, L.P.
| UBER FREIGHT HOLDING CORP
| CROW-S NEST HOLDINGS ONSHORE FUND LP
| CROW-S NEST HOLDINGS OFFSHORE FUND LTD
| GB RW CO-INVEST A, LP
| GB RW CO-INVEST, LP
| CHECKPOINT THERAPEUTICS, INC.
| GENCAP MIDDLETON INDUSTRIAL MM, LLC
| GENCAP JANESVILLE INDUSTRIAL MM, LLC
| GENCAP MCCORMICK INDUSTRIAL MM, LLC
| GENCAP BROOKFIELD LAKES MM, LLC
| GENCAP GLENDALE INDUSTRIAL MM, LLC
| GENCAP GURNEE MM, LLC
| CROW-S NEST HOLDINGS SAG, LLC
MICHAEL
S.
WEISS
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-07-02
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-01-27
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2015-09-30

